136 related articles for article (PubMed ID: 33516143)
1. The effects of KaiXinSan on depression and its association with lipid profiles: A randomized, double-blinded, placebo-controlled trial.
Hu Y; Chen C; Wang Y; Yang W; Wang Y; Zhu W; Yan C; Liu P
Phytomedicine; 2021 Mar; 83():153467. PubMed ID: 33516143
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled, double-blind study on the effects of SZL on patients with mild to moderate depressive disorder with comparison to fluoxetine.
Hu Y; Wang Y; Chen C; Yang W; Zhu W; Wang Y; Liu P
J Ethnopharmacol; 2021 Dec; 281():114549. PubMed ID: 34438029
[TBL] [Abstract][Full Text] [Related]
3. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis.
Zhou X; Wang J; Lu Y; Chen C; Hu Y; Liu P; Dong X
J Ethnopharmacol; 2020 Apr; 252():112615. PubMed ID: 31991203
[TBL] [Abstract][Full Text] [Related]
4. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.
Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F
J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009
[TBL] [Abstract][Full Text] [Related]
5. Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system.
Cao C; Liu M; Qu S; Huang R; Qi M; Zhu Z; Zheng J; Chen Z; Wang Z; Han Z; Zhu Y; Huang F; Duan JA
J Ethnopharmacol; 2020 Oct; 261():113055. PubMed ID: 32592887
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant and neuroprotective effect of the Chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-induced injury in vitro and in vivo.
Hu Y; Zhou XJ; Liu P; Dong XZ; Mu LH; Chen YB; Liu MY; Yu BY
Neuropsychobiology; 2014; 69(3):129-39. PubMed ID: 24776773
[TBL] [Abstract][Full Text] [Related]
7. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.
Gao HL; Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Yan GL; Liu L; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():286-295. PubMed ID: 29933222
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
[TBL] [Abstract][Full Text] [Related]
9. Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression.
Hu Y; Dong X; Zhang T; Ma H; Yang W; Wang Y; Liu P; Chen Y
Mol Med Rep; 2020 Jan; 21(1):508-516. PubMed ID: 31746394
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Kaixinsan on monoamine oxidase activity].
Wang S; Dong XZ; Tan X; Wang YN; Liu P
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1898-1902. PubMed ID: 28895340
[TBL] [Abstract][Full Text] [Related]
11. Kai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus.
Zhu Y; Chao C; Duan X; Cheng X; Liu P; Su S; Duan J; Dong TT; Tsim KW
Sci Rep; 2017 May; 7(1):1467. PubMed ID: 28469194
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the efficacy and safety of the traditional Chinese medicine formula Kaixinsan decoction for depression.
Li JL; Lin L; Wu MM; Zhang JY; Zhang YX; Cao MR; Wang L
Medicine (Baltimore); 2024 Jan; 103(1):e36719. PubMed ID: 38181245
[TBL] [Abstract][Full Text] [Related]
13. Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review.
Fu H; Xu Z; Zhang XL; Zheng GQ
Front Neurosci; 2019; 13():1421. PubMed ID: 32009890
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
15. KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats.
Wang Y; Li X; Jing R; Yang W; Wang Y; Wang C; Yao L; Cui X; Hu Y
Neuropsychiatr Dis Treat; 2022; 18():2485-2496. PubMed ID: 36345420
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats.
Dong XZ; Wang DX; Lu YP; Yuan S; Liu P; Hu Y
Braz J Med Biol Res; 2017 Aug; 50(10):e6161. PubMed ID: 28832762
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of depression.
Du LJ; Zhang XN; Li SS; Sun YF; Jin HZ; Yan SK; Han CG
Metab Brain Dis; 2022 Dec; 37(8):2903-2914. PubMed ID: 36070047
[TBL] [Abstract][Full Text] [Related]
18. Xiaoyao Pills, a Chinese patent medicine, treats mild and moderate depression: A randomized clinical trial combined with DNA methylation analysis.
Fan L; Zeng P; Wang X; Mo X; Ma Q; Zhou X; Yuan N; Liu Y; Xue Z; Huang J; Li X; Ding J; Chen J
Phytomedicine; 2024 Jul; 130():155660. PubMed ID: 38815407
[TBL] [Abstract][Full Text] [Related]
19. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress.
Dang H; Sun L; Liu X; Peng B; Wang Q; Jia W; Chen Y; Pan A; Xiao P
Exp Biol Med (Maywood); 2009 Jul; 234(7):785-93. PubMed ID: 19429857
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms.
Bo M; Zhang H; Xu J; Zhao H; Jia X; Wang G; Lu Z
Front Behav Neurosci; 2022; 16():1061877. PubMed ID: 36560929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
